A multicenter pharmacosurveillance study for the evaluation of the efficacy and safety of recombinant factor VIII in the treatment of patients with hemophilia A. The German Kogenate Study Group - Aygoren-Pursun,E.; Scharrrer,I. (Thromb Haemost, 1997)